Table 3.

Distribution of antiviral regimens among 334 HIV/HBV co-infected patients on current anti-HBV treatment

Treatment	n	(%)
TDF + LAM/FTC	235	70.4
LAM	60	18
TDF	17	5.1
Telbivudine	6	1.8
PEG-IFN§	6	1.8
Other combo NUC*	5	1.5
ETV	3	0.9
ADV	2	0.6
Total	334	100

^§ + TDF = 4; ^*ADV + LAM =4, ADV + ETV =1.